|
Gimeno L, Serrano-Lopez EM, Campillo JA, Canovas-Zapata MA, Acuna OS, Garcia-Cozar F, Martinez-Sanchez MV, Martinez-Hernandez MD, Soto-Ramirez MF, Lopez-Cubillana P, Martinez-Escribano J, Martinez-Garcia J, Corbalan-Garcia S, Alvarez-Lopez MR, Minguela A. KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling. Cancers (Basel). 2020 Oct 15;12(10):2991. doi: 10.3390/cancers12102991. PubMed PMID: 33076479; PubMed Central PMCID: PMC7650600.
AÑO: 2020; IF: 6.639
|
33076479
|
Almaida-Pagán PF, Seco-Rovira V, Hernández MD, Madrid JA, De Costa J, Mendiola P. Energy intake and macronutrient selection in sharpsnout seabream (Diplodus puntazzo) challenged with fat dilution and fat deprivation using encapsulated diets. Physiol Behav. 2008 Feb 27;93(3):474-80. Epub 2007 Oct 12. PubMed PMID: 17997462.
AÑO: 2008; IF: 2.826
|
|
Vasco-Mogorron MA, Campillo JA, Periago A, Cabanas V, Berenguer M, Garcia-Garay MC, Gimeno L, Soto-Ramirez MF, Martinez-Hernandez MD, Muro M, Minguela A. Proliferation to Apoptosis Tumor Cell Ratio as a Biomarker to Improve Clinical Management of Pre-Malignant and Symptomatic Plasma Cell Neoplasms. Int J Mol Sci. 2021 Apr 9;22(8):3895. doi: 10.3390/ijms22083895. PubMed PMID: 33918790; PubMed Central PMCID: PMC8068942.
AÑO: 2021; IF: 6.208
|
|
Vasco-Mogorron MA, Campillo JA, Periago A, Cabanas V, Berenguer M, Garcia-Garay MC, Gimeno L, Soto-Ramirez MF, Martinez-Hernandez MD, Muro M, Minguela A. Blood-based risk stratification for pre-malignant and symptomatic plasma cell neoplasms to improve patient management. Am J Cancer Res. 2021 Jun 15;11(6):2736-2753. eCollection 2021. PubMed PMID: 34249425; PubMed Central PMCID: PMC8263680.
AÑO: 2021; IF: 5.942
|
|
Minguela A, Vasco-Mogorron MA, Campillo JA, Cabanas V, Remigia MJ, Berenguer M, Garcia-Garay MC, Blanquer M, Cava C, Galian JA, Gimeno L, Soto-Ramirez MF, Martinez-Hernandez MD, de la Rubia J, Teruel AI, Muro M, Periago A. Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment. Am J Cancer Res. 2021 Sep 15;11(9):4438-4454. eCollection 2021. PubMed PMID: 34659897; PubMed Central PMCID: PMC8493371.
AÑO: 2021; IF: 5.942
|